Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 23475638)

1.

Treating iron overload in patients with non-transfusion-dependent thalassemia.

Taher AT, Viprakasit V, Musallam KM, Cappellini MD.

Am J Hematol. 2013 May;88(5):409-15. doi: 10.1002/ajh.23405. Epub 2013 Mar 8. Review.

2.

Fertility in transfusion-dependent thalassemia men: Effects of iron burden on the reproductive axis.

Singer ST, Killilea D, Suh JH, Wang ZJ, Yuan Q, Ivani K, Evans P, Vichinsky E, Fischer R, Smith JF.

Am J Hematol. 2015 Jun 4. doi: 10.1002/ajh.24083. [Epub ahead of print] No abstract available.

PMID:
26044409
3.

Iron overload in transfusion-dependent thalassemia.

Saliba A, Taher A.

Hematology. 2015 Jun;20(5):311-2. doi: 10.1179/1024533215Z.000000000365. No abstract available.

PMID:
25967377
4.

Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.

Inthawong K, Charoenkwan P, Silvilairat S, Tantiworawit A, Phrommintikul A, Choeyprasert W, Natesirinilkul R, Siwasomboon C, Visrutaratna P, Srichairatanakool S, Chattipakorn N, Sanguansermsri T.

Hematology. 2015 May 12. [Epub ahead of print]

PMID:
25964094
5.

Non-transfusion-dependent thalassemia: a complex mix of genetic entities yet to be fully discovered.

Ricchi P, Filosa A, Maggio A, Fucharoen S.

Biomed Res Int. 2015;2015:161434. doi: 10.1155/2015/161434. Epub 2015 Apr 6. No abstract available.

6.

The dangerous outcomes of blood transfusion to thalassemia patients in Pakistan.

Shah DA.

J Infect Public Health. 2015 Feb 26. pii: S1876-0341(15)00008-8. doi: 10.1016/j.jiph.2015.01.002. [Epub ahead of print] No abstract available.

PMID:
25731675
7.

Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up.

Jin P, Wang J, Li X, Wang M, Ge M, Zhang J, Huang J, Zhang J, Huang Z, Nie N, Shao Y, Shi J, Zheng Y.

Int J Hematol. 2015 Jan;101(1):13-22. doi: 10.1007/s12185-014-1708-6. Epub 2014 Nov 28.

PMID:
25430083
8.

A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: The E-SAAN score.

Teawtrakul N, Pussadhamma B, Ungprasert P, Prayalaw P, Fucharoen S, Jetsrisuparb A, Pongudom S, Sirijerachai C, Chansung K, Wanitpongpun C, Thongbuaban S, Thinkhamrop B, Chuncharunee S.

Hematology. 2014 Nov 11. [Epub ahead of print]

PMID:
25386747
9.

Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.

El Sayed SM, Baghdadi H, Abou-Taleb A, Mahmoud HS, Maria RA, Ahmed NS, Helmy Nabo MM.

J Blood Med. 2014 Oct 30;5:219-37. doi: 10.2147/JBM.S65042. eCollection 2014. Review.

10.

When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.

Taher AT, Radwan A, Viprakasit V.

Vox Sang. 2015 Jan;108(1):1-10. doi: 10.1111/vox.12201. Epub 2014 Oct 7.

11.

[Current management of thalassemia intermedia].

Thuret I.

Transfus Clin Biol. 2014 Nov;21(4-5):143-9. doi: 10.1016/j.tracli.2014.07.005. Epub 2014 Oct 2. French.

PMID:
25282488
12.

Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition.

Viprakasit V, Tyan P, Rodmai S, Taher AT.

Orphanet J Rare Dis. 2014 Sep 30;9:131. doi: 10.1186/s13023-014-0131-7. Review.

13.

Management of non-transfusion-dependent thalassemia: a practical guide.

Taher AT, Cappellini MD.

Drugs. 2014 Oct;74(15):1719-29. doi: 10.1007/s40265-014-0299-0.

PMID:
25255924
14.

Desferioximine induced Ototoxicity in Thalassemic patients.

Vir D, Panda NK, Marwaha RK.

Ann Neurosci. 2010 Oct;17(4):182-4. doi: 10.5214/ans.0972.7531.1017407.

15.

Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy.

Sait S, Zaghloul N, Patel A, Shah T, Iacobas I, Calderwood S.

Pediatr Blood Cancer. 2014 Dec;61(12):2319-20. doi: 10.1002/pbc.25189. Epub 2014 Aug 23.

PMID:
25154390
16.

Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia.

Tyan PI, Radwan AH, Eid A, Haddad AG, Wehbe D, Taher AT.

Biomed Res Int. 2014;2014:350432. doi: 10.1155/2014/350432. Epub 2014 Jul 9.

17.

Iron chelation for iron overload secondary to transfusions of packed red blood cells.

Cid J.

Clin Adv Hematol Oncol. 2014 Mar;12(3):184-5. No abstract available.

PMID:
24927267
18.

Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement.

Ko BS, Chang CS, Chang MC, Chen TY, Chiou TJ, Chiu CF, Huang WL, Kao WY, Lan YJ, Lin SF, Tan TD, Tang JL, Tzeng CH, Wang PN, Yet SP, Tien HF.

Int J Hematol. 2014 Jul;100(1):7-15. doi: 10.1007/s12185-014-1607-x. Epub 2014 Jun 13.

PMID:
24924953
19.

Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Coates TD.

Free Radic Biol Med. 2014 Jul;72:23-40. doi: 10.1016/j.freeradbiomed.2014.03.039. Epub 2014 Apr 12. Review.

PMID:
24726864
20.

Current approach to iron chelation in children.

Aydinok Y, Kattamis A, Viprakasit V.

Br J Haematol. 2014 Jun;165(6):745-55. doi: 10.1111/bjh.12825. Epub 2014 Mar 20. Review.

PMID:
24646011
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk